Poster 44

Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial

Authors: Loretta Fiorillo, MD; Emily Becker, MD; Susana Armesto, MD; Amy S. Paller, MD; Apostolos Kontzias, MD; Rajneet K. Oberoi, BPharm, PhD; Yuri Klyachkin, PhD; Hamid Amouzadeh, PhD; Zuoshun Zhang, PhD; Lisa Arkin, MD

<PREVIOUS POSTER | NEXT POSTER>

Poster 44